# Pfizer Inc. (PFE) — Q2-2021 Earnings Results

**Report date:** 2021-07-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q2-2021

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Up 3.21%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.98 | N/A | +0.20% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific revenue figures or guidance.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering innovative solutions to our customers.

### Guidance Changes

No guidance data was provided in this earnings report.

### What It Means

Pfizer's earnings report showed a positive surprise in EPS, which contributed to a 3.21% increase in stock price. The lack of revenue data and guidance leaves some uncertainty, but the EPS beat suggests strong performance in key areas. Investors may view this as a sign of resilience amid ongoing market challenges.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q2-2021_